T. Rowe Price Investment Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175M | Sell |
1,394,476
-1,265,814
| -48% | -$159M | 0.11% | 195 |
|
|
2025
Q1 | $364M | Sell |
2,660,290
-439,496
| -14% | -$60.1M | 0.24% | 112 |
|
|
2024
Q4 | $474M | Sell |
3,099,786
-1,156,500
| -27% | -$177M | 0.29% | 99 |
|
|
2024
Q3 | $825M | Sell |
4,256,286
-1,422,573
| -25% | -$276M | 0.5% | 61 |
|
|
2024
Q2 | $1.32B | Buy |
5,678,859
+508,889
| +10% | +$118M | 0.83% | 28 |
|
|
2024
Q1 | $1.11B | Sell |
5,169,970
-187,356
| -3% | -$40.4M | 0.68% | 40 |
|
|
2023
Q4 | $1.39B | Buy |
5,357,326
+602,335
| +13% | +$156M | 0.9% | 23 |
|
|
2023
Q3 | $1.22B | Buy |
4,754,991
+1,355,921
| +40% | +$348M | 0.86% | 25 |
|
|
2023
Q2 | $968M | Buy |
+3,399,070
| New | +$968M | 0.66% | 36 |
|